Patent Information

Intellectual property and innovation at Enigma Genetics.

Patent Pending

System and Method for Self-Sovereign Genetic Identity, Epigenetic Mapping, and Consent-Controlled Data Exchange

A comprehensive framework for enabling individuals to maintain complete control over their genetic data while participating in research and healthcare applications.

Status: Patent Pending

Filing Date: 2024

Trademarks

The following marks are trademarks of Enigma Genetics LLC:

Cypherglyph™
GeneVault™
SignaChain™
Unifacator™
OmniMind™
Enigma Genetics™

Key Innovations

Self-Sovereign Identity Architecture

Novel approach to genetic data ownership that places control entirely in the hands of individuals.

Encrypted Collaboration Framework

Privacy-preserving protocols that enable research without compromising participant anonymity.

Consent Management System

Dynamic, granular consent controls with immutable audit trails.

Licensing Inquiries

For information about licensing our technology or partnerships:

licensing@enigmagenetics.com